153619-26-2 Usage
General Description
The chemical "(2R)-2-({[(5S,6S)-6,9,14-trihydroxy-5-{[(2S,3R,4S,5S,6R)-3-hydroxy-6-methyl-5-(methylamino)-4-{[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]oxy}tetrahydro-2H-pyran-2-yl]oxy}-1,11-dimethoxy-3-methyl-8,13-dioxo-5,6,8,13-tetrahydrobenzo[a]tetracen" is a complex organic compound with a long, intricate molecular structure. It contains multiple hydroxyl groups and oxygens, and comprises of various interconnected rings and branches. The chemical's configuration includes multiple chiral centers, with the specified stereochemistry denoting the arrangement of atoms in the molecule. This detailed structure suggests that the compound may have pharmaceutical or biological significance and may require advanced techniques for synthesis and analysis.
Check Digit Verification of cas no
The CAS Registry Mumber 153619-26-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,3,6,1 and 9 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 153619-26:
(8*1)+(7*5)+(6*3)+(5*6)+(4*1)+(3*9)+(2*2)+(1*6)=132
132 % 10 = 2
So 153619-26-2 is a valid CAS Registry Number.
153619-26-2Relevant articles and documents
Synthesis and antifungal activity of pradimicin derivatives. Modifications on the aglycone part
Aburaki,Okuyama,Hoshi,Kamachi,Nishio,Hasegawa,Masuyoshi,Imura,Konishi,Oki
, p. 1447 - 1457 (2007/10/02)
Synthesis and antifungal activity of pradimicin analogs modified on the aglycone part is described. Upon modification studies at various sites of the aglycone part using pradimicin A (PRM A), C-11 position was found to be the sole site to be modified with
